Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.
Completed · Phase 3
Conditions studied: Renal Function, Liver Transplant
In brief
This study was designed to assess the evolution of renal function and to collect efficacy, safety, and tolerability data of everolimus in co-exposure with reduced CNI in paediatric liver transplant recipients.
Key facts
- Study ID
- NCT01598987
- Run by
- Novartis Pharmaceuticals
- People needed
- 56
- Starts
- 2012-10-01
- Expected to finish
- 2016-06-01
- Last updated by the study team
- 2017-05-16
Who can join
Age: 0 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Novartis Investigative Site — Los Angeles, California, United States
- Novartis Investigative Site — New Haven, Connecticut, United States
- Novartis Investigative Site — Chicago, Illinois, United States
- Novartis Investigative Site — St Louis, Missouri, United States
- Novartis Investigative Site — New York, New York, United States
- Novartis Investigative Site — Charleston, South Carolina, United States
- Novartis Investigative Site — Houston, Texas, United States
- Novartis Investigative Site — Salt Lake City, Utah, United States
- Novartis Investigative Site — Madison, Wisconsin, United States
- Novartis Investigative Site — Parkville, Victoria, Australia
- Novartis Investigative Site — Brussels, Belgium
- Novartis Investigative Site — Edmonton, Alberta, Canada
- Novartis Investigative Site — København Ø, Denmark
- Novartis Investigative Site — Bron, France
- Novartis Investigative Site — Hanover, Germany, Germany
- Novartis Investigative Site — Bonn, Germany
- Novartis Investigative Site — Essen, Germany
- Novartis Investigative Site — Hamburg, Germany
- Novartis Investigative Site — Regensburg, Germany
- Novartis Investigative Site — Tübingen, Germany
- Novartis Investigative Site — Budapest, Hungary
- Novartis Investigative Site — Budapest, Hungary
- Novartis Investigative Site — Bergamo, BG, Italy
- Novartis Investigative Site — Roma, ITA, Italy
- Novartis Investigative Site — Padova, PD, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.